Matches in Wikidata for { <http://www.wikidata.org/entity/Q89726834> ?p ?o ?g. }
Showing items 1 to 37 of
37
with 100 items per page.
- Q89726834 description "artículu científicu espublizáu en febreru de 2020" @default.
- Q89726834 description "scientific article published on 15 February 2020" @default.
- Q89726834 description "wetenschappelijk artikel" @default.
- Q89726834 description "наукова стаття, опублікована 15 лютого 2020" @default.
- Q89726834 name "Intermittent dosing of the transforming growth factor beta receptor 1 inhibitor, BMS-986260, mitigates class-based cardiovascular toxicity in dogs but not rats" @default.
- Q89726834 name "Intermittent dosing of the transforming growth factor beta receptor 1 inhibitor, BMS-986260, mitigates class-based cardiovascular toxicity in dogs but not rats" @default.
- Q89726834 type Item @default.
- Q89726834 label "Intermittent dosing of the transforming growth factor beta receptor 1 inhibitor, BMS-986260, mitigates class-based cardiovascular toxicity in dogs but not rats" @default.
- Q89726834 label "Intermittent dosing of the transforming growth factor beta receptor 1 inhibitor, BMS-986260, mitigates class-based cardiovascular toxicity in dogs but not rats" @default.
- Q89726834 prefLabel "Intermittent dosing of the transforming growth factor beta receptor 1 inhibitor, BMS-986260, mitigates class-based cardiovascular toxicity in dogs but not rats" @default.
- Q89726834 prefLabel "Intermittent dosing of the transforming growth factor beta receptor 1 inhibitor, BMS-986260, mitigates class-based cardiovascular toxicity in dogs but not rats" @default.
- Q89726834 P1433 Q89726834-F295744E-236B-4E5B-8976-7532272F1DBD @default.
- Q89726834 P1476 Q89726834-BB8892A7-5F80-4CDA-9BBE-E365C7A5E8B0 @default.
- Q89726834 P2093 Q89726834-13A4D8DD-DA64-4A6B-8F13-FC4D53297422 @default.
- Q89726834 P2093 Q89726834-2D8A0F8D-686A-4CCF-9492-75CFB159EB75 @default.
- Q89726834 P2093 Q89726834-38B87EDB-2E62-4B94-AFE1-9B618B87B315 @default.
- Q89726834 P2093 Q89726834-811AE5B5-2882-4CED-AF39-E71E47D71296 @default.
- Q89726834 P2093 Q89726834-C16E5999-C313-4010-9A37-81032332FB36 @default.
- Q89726834 P31 Q89726834-A78CCA94-E46B-446B-A7BE-A18F36DA2C10 @default.
- Q89726834 P356 Q89726834-8DEE6DD2-7D89-464C-8BDF-A2BBAFFA9B0B @default.
- Q89726834 P50 Q89726834-DE2DA2B8-9DB2-4913-BE9A-18C3C174FB5F @default.
- Q89726834 P577 Q89726834-B2C98A0E-5527-4CD1-ABFA-6C00CDD7ED3B @default.
- Q89726834 P698 Q89726834-4CE0C44C-B092-4944-AE5B-75803233D79A @default.
- Q89726834 P356 JAT.3954 @default.
- Q89726834 P698 32061184 @default.
- Q89726834 P1433 Q3186896 @default.
- Q89726834 P1476 "Intermittent dosing of the transforming growth factor beta receptor 1 inhibitor, BMS-986260, mitigates class-based cardiovascular toxicity in dogs but not rats" @default.
- Q89726834 P2093 "Courtni Newsome" @default.
- Q89726834 P2093 "Gene E Schulze" @default.
- Q89726834 P2093 "Karen Augustine-Rauch" @default.
- Q89726834 P2093 "Melvin R White" @default.
- Q89726834 P2093 "Michael J Graziano" @default.
- Q89726834 P31 Q13442814 @default.
- Q89726834 P356 "10.1002/JAT.3954" @default.
- Q89726834 P50 Q89726831 @default.
- Q89726834 P577 "2020-02-15T00:00:00Z" @default.
- Q89726834 P698 "32061184" @default.